Soffer MD, Adams ZM, Chen YS, Fox NS. Risk factors for positive postpartum depression screen in women with private health insurance and access to care. J Matern Fetal Neonatal Med. 2019;32(24):4154–8.

Article  CAS  PubMed  Google Scholar 

Liu D, Ma Y, Yu G, Kuang J. Meta analysis of the detection rate of postpartum depression in China. Chinese Journal of Evidence Based Medicine. 2019;19(12):1409–15.

Google Scholar 

Li L, An X, Zhang J, Huang L, Zhang X. Meta analysis of the detection rate of postpartum depression in elderly mothers in China. Chinese Journal of General Medicine. 2024;27(11):1363–9.

Google Scholar 

Payne JL, Maguire J. Pathophysiological mechanisms implicated in postpartum depression. Front Neuroendocrinol. 2019;52:165–80.

Article  CAS  PubMed  Google Scholar 

Thul TA, Corwin EJ, Carlson NS, et al. Oxytocin and postpartum depression: a systematic review. Psychoneuroendocrinology. 2020;120:104793.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Naoi M, Maruyama W, Shamoto-Nagai M. Type A monoamine eoxidase and serotonin are coordinately involved in depressive disorders: from neurotransmitter imbalance to im-paired neurogenesis. J Neural Transm(Vienna). 2017; 5 (14): 196–203.

Lee Y, Kim KH, Lee BH, Kim YK. Plasma level of brainderived neurotrophic factor (BDNF) in patients with postpartum depression. Prog NeuropsychopharmacolBiol Psychiatry. 2021;109: 110245.

Article  CAS  Google Scholar 

Zanos P, Moaddel R, Morris PJ, Riggs LM, Highland JN, Georgiou P, Pereira EFR, Albuquerque EX, Thomas CJ, Zarate CA Jr, Gould TD. Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms. Pharmacol Rev. 2018;70(3):621–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ago Y, Tanabe W, Higuchi M, Tsukada S, Tanaka T, Yamaguchi T, Igarashi H, Yokoyama R, Seiriki K, Kasai A, Nakazawa T, Nakagawa S, Hashimoto K, Hashimoto H. R-ketamine induces a greater increase in prefronlal 5-HT release than S-ketamine and ketamine metabolites via an AMPA receptor independent mechanism. Int J Neuropsychopharmacol. 2019;22(10):665–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gu P, Jiang X, Du B, Yao L, Song J. The effect of s-ketamine PCIA on postpartum depression in pregnant women undergoing cesarean section. Chinese Journal of Anesthesiology. 2021;41(3):274–7.

Google Scholar 

Liu Y, Li X. The effect of s-ketamine combined with hydromorphone on postoperative analgesia and postpartum depression after cesarean section. Shandong Medical Journal. 2021;61(19):84–7.

Google Scholar 

Singh JB, Fedgchin M, Daly E, Xi L, Melman C, De Bruecker G, Tadic A, Sienaert P, Wiegand F, Manji H, Drevets WC, Van Nueten L. Intravenous S-ketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization. Placebo-Controlled Study Biological Psychiatry. 2016;80(6):424–31.

Article  CAS  PubMed  Google Scholar 

Wojdacz R, Swieciki L, Antosik-Wojcinska A. Comparison of the effect of intravenous anesthetics used for anesthesiaduring electroconvulsive therapy on the hemodynamic safety andthe course of ECT. Psychiatr Pol. 2017;51(6):1039–58.

Article  PubMed  Google Scholar 

Esscher A, Essén B, Innala E, Papadopoulos FC, Skalkidou A, Sundström-Poromaa I, Högberg U. Suicides during pregnancy and 1 year postpartum in Sweden, 1980–2007. Br J Psychiatry. 2016;208(5):462–9.

Article  PubMed  Google Scholar 

Stein A, Pearson RM, Goodman SH, Rapa E, Rahman A, McCallum M, Howard LM, Pariante CM. Effects of perinatal mental disorders on the fetus and child. Lancet. 2014;384(9956):1800–19.

Article  PubMed  Google Scholar 

Roomruangwong C, Withayavanitchai S, Maes M. A ntenatal and postnatal risk factors of postpartum depression symptom s in Thai women: A case-controlstudy. Sex Reprod Healthc. 2016;12(10):25–31.

Article  Google Scholar 

Hare BD, Shinohara R, Liu RJ, Pothula S, DiLeone RJ, Duman RS. Optogenetic stimulation of medial prefrontal cortex Drdl neurons produces rapid and long-lasting antidepressant effects. Nat Commun. 2019;10(1):223.

Article  PubMed  PubMed Central  Google Scholar 

Gerrits MM, van Oppen P, Leone SS, van Marwijk HW, van der Horst HE, Penninx BW. Pain, not chronic disease, is associated with the recurrence of depressive and anxiety disorders. BMC Psychiatry. 2014;14(1):1–9.

Article  Google Scholar 

Pham TH, Mendez-David I, Defaix C, Guiard BP, Tritschler L, David DJ, Gardier AM. Katamine treatment involves medical prefrontal corte serotonin to induce a rapid antidepressant-like activity in BALB/cJmice. Neuropharmacology. 2017;112(Pt A):198–209.

Article  CAS  PubMed  Google Scholar 

Schalzberg AF. Mechanisms of action of ketamine and eskatemine. Am J Psychiatry. 2021;178(12):1130.

Article  Google Scholar 

Mihaljevic S, Pavlovi M, Reiner K, Cacic M. Therapeutic mechanisms of katemine. Psychiar Danub. 2020;32(3–4):325–33.

Article  CAS  Google Scholar 

Findeis H, Sauer C, Cleare A, Bauer M, Ritter P. Urothelial toxicity of s-ketamine in the treatment of depression. Psychopharmacology (Berl). 2020;237(11):3295–302.

Article  CAS  PubMed  Google Scholar 

Zhou Y, Wang S, Yang M, Huang Z, Ma J, Duan K. Analysis of the correlation between BDNF gene polymorphism and postpartum depression in cesarean section women. Chinese Journal of Medicine. 2017;42(6):538–44.

Google Scholar 

Liu P, Li P, Li Q, Yan H, Shi X, Liu C, Zhang Y, Peng S. Effect of pretreatment of S-ketamine on postoperative depression for breast cancer patients. J Invest Surg. 2020;16:1–6.

Google Scholar 

Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, Ionescu DF, Mathew SJ, Chang LC, Iosifescu DV, Murrough J, Debattista C, Schatzberg AF, Trivedi MH, Jha MK, Sanacora G, Wilkinson ST, Papakostas GI. Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). Mol Psychiatry. 2020;25:1592–603.

Article  CAS  PubMed  Google Scholar 

Schwartz J, Murrough JW, Iosifescu DV. Short term ketamine administration for refractory depression: focusing on cardiovascular safety. Psychiatry Danub. 2019;31(Supplementary 3):585–90.

Google Scholar 

McIntyre RS, Rosenblat JD, Nemeroff CB, Sanacora G, Murrough JW, Berk M, Brietzke E, Dodd S, Gorwood P, Ho R, Iosifescu DV, Lopez Jaramillo C, Kasper S, Kratiuk K, Lee JG, Lee Y, Lui LMW, Mansur RB, Papakostas GI, Subramaniapillai M, Thase M, Vieta E, Young AH, Zarate CA Jr, Stahl S. Synthesizing the Evidence for Ketamine and S-ketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation. Psychiatry. 2021;178(5):383–99.

Google Scholar 

Shang Y, Li S, Zheng Q, et al. Study on the effect of different doses of intravenous ketamine on postoperative depression in cesarean section women. Chinese Maternal and Child Health Research. 2023;34(9):28–34.

Google Scholar 

Trujillo KA, Heller CY. Ketamine sensitization: Influence of dose, environment, social isolation and treatment interval. Behav Brain Res. 2020;378: 112271.

Article  CAS  PubMed  Google Scholar 

Li L, Vlisides PE. Ketamine: 50 years of modulating the mind. Front Hum Neurosci. 2016;10:612.

Article  PubMed  PubMed Central  Google Scholar 

Dandan L, Xiao H, Changwei W, et al. Meta-analysis of the effects of perioperative ketamine application on postpartum depression in cesarean section mothers. Journal of Clinical Anesthesiology. 2021;37(05):506–10.

Google Scholar 

Wajs E, Aluisio L, Holder R, et al. Esketamine nasal spray plus oral antidepression in patients with treatment-resistant depression: assessment of long-term safety in a phase 3, open-label study(SUSTAIN). J Clin Psychiatry. 2020;81:19ml12891.

Article  Google Scholar